Roche Holding AG (RHHBY)
32.18
-0.46
(-1.41%)
USD |
OTCM |
Mar 18, 16:00
Roche Total Liabilities (Quarterly): 68.11B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 68.11B |
June 30, 2023 | 60.08B |
June 30, 2023 | 60.08B |
December 31, 2022 | 60.55B |
June 30, 2022 | 60.55B |
June 30, 2022 | 60.55B |
December 31, 2021 | 69.98B |
June 30, 2021 | 50.44B |
June 30, 2021 | 50.44B |
December 31, 2020 | 53.07B |
June 30, 2020 | 47.89B |
June 30, 2020 | 47.89B |
December 31, 2019 | 48.74B |
June 30, 2019 | 50.34B |
June 30, 2019 | 50.34B |
December 31, 2018 | 48.91B |
June 30, 2018 | 48.13B |
June 30, 2018 | 48.13B |
December 31, 2017 | 48.94B |
June 30, 2017 | 48.73B |
June 30, 2017 | 48.73B |
December 31, 2016 | 49.55B |
June 30, 2016 | 54.54B |
June 30, 2016 | 54.54B |
December 31, 2015 | 53.08B |
Date | Value |
---|---|
June 30, 2015 | 53.63B |
June 30, 2015 | 53.63B |
December 31, 2014 | 54.59B |
June 30, 2014 | 47.67B |
June 30, 2014 | 47.67B |
December 31, 2013 | 46.12B |
June 30, 2013 | 45.85B |
June 30, 2013 | 45.85B |
December 31, 2012 | 52.64B |
June 30, 2012 | 49.24B |
June 30, 2012 | 49.24B |
December 31, 2011 | 50.05B |
June 30, 2011 | 53.34B |
June 30, 2011 | 53.34B |
December 31, 2010 | 52.80B |
June 30, 2010 | 51.99B |
December 31, 2009 | 62.91B |
June 30, 2009 | 65.63B |
December 31, 2008 | 20.84B |
June 30, 2008 | 21.06B |
June 30, 2008 | 21.06B |
December 31, 2007 | 21.99B |
June 30, 2007 | 21.41B |
June 30, 2007 | 21.41B |
December 31, 2006 | 22.62B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
47.89B
Minimum
Jun 2020
69.98B
Maximum
Dec 2021
55.94B
Average
53.07B
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
Novartis AG | 53.20B |
Pfizer Inc | 137.21B |
Gilead Sciences Inc | 39.38B |
Eli Lilly and Co | 53.14B |
CRISPR Therapeutics AG | 346.77M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 107.71B |
Shareholders Equity (Quarterly) | 34.90B |
Debt to Equity Ratio | 0.9964 |
Current Ratio | 1.347 |
Net Debt Paydown Yield | -0.82% |